Gwang-Cheol Park
Chief Executive Officer at Premierbio Co., Ltd.
Profile
Gwang-Cheol Park is currently the Chief Executive Officer at Premierbio Co., Ltd.
Prior to this, he was the Chairman & Co-Chief Executive Officer at DSK Co., Ltd.
and an Independent Director at KB Securities Co., Ltd.
He received his undergraduate, graduate, and doctorate degrees from Konkuk University.
Gwang-Cheol Park active positions
| Companies | Position | Start |
|---|---|---|
Premierbio Co., Ltd.
 Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Chief Executive Officer | - |
Former positions of Gwang-Cheol Park
| Companies | Position | End |
|---|---|---|
| DSK CO., LTD. | Chief Executive Officer | - |
| HYUNDAI SECURITIES CO LTD | Director/Board Member | - |
Training of Gwang-Cheol Park
| Konkuk University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| DSK CO., LTD. | Electronic Technology |
| Private companies | 2 |
|---|---|
KB Securities Co., Ltd
 KB Securities Co., Ltd Investment ManagersFinance KB Securities Co., Ltd (KB Securities) is a private equity subsidiary of KB Financial Group, Inc. founded in 1962. The firm is headquartered in Seoul, South Korea. | Finance |
Premierbio Co., Ltd.
Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Health Technology |
- Stock Market
- Insiders
- Gwang-Cheol Park
